Proton MR spectroscopy detects a relative decrease of N-acetylaspartate in the medial temporal lobe of patients with AD.
about
Computed tomography of amyloid plaques in a mouse model of Alzheimer's disease using diffraction enhanced imaging.Proton MRS in mild cognitive impairment.Magnetic resonance spectroscopy in Alzheimer's disease.Magnetic resonance spectroscopy in common dementiasMagnetic resonance imaging and magnetic resonance spectroscopy in dementias[Alzheimer's disease and magnetic resonance spectroscopy of the hippocampus].Various MRS application tools for Alzheimer disease and mild cognitive impairment.Imaging of Alzheimer's disease.Neuroimaging characteristics of dementia with Lewy bodies.1H-MRS evaluation of metabolism in Alzheimer's disease and vascular dementia.Imaging in psychiatric illnesses.Quantitative magnetic resonance techniques as surrogate markers of Alzheimer's disease.Neuroimaging biomarkers for clinical trials of disease-modifying therapies in Alzheimer's disease.A comparative study of the different N-acetylaspartate measures of the medial temporal lobe in Alzheimer's disease.Magnetic Resonance Spectroscopy in Alzheimer's Disease: Systematic Review and Meta-Analysis.A multicenter reproducibility study of single-voxel 1H-MRS of the medial temporal lobe.Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics.Magnetic resonance imaging of Alzheimer's disease.MR spectroscopy in neurodegenerative disease.Alzheimer disease: postmortem neuropathologic correlates of antemortem 1H MR spectroscopy metabolite measurements.MR spectroscopy, functional MRI, and diffusion-tensor imaging in the aging brain: a conceptual review.Multinuclear magnetic resonance spectroscopy for in vivo assessment of mitochondrial dysfunction in Parkinson's disease.Improvements in high-field localized MRS of the medial temporal lobe in humans using new deformable high-dielectric materials.7.0T nuclear magnetic resonance evaluation of the amyloid beta (1-40) animal model of Alzheimer's disease: comparison of cytology verification.Magnetic resonance spectroscopy in vivo of neurochemicals in a transgenic model of Alzheimer's disease: a longitudinal study of metabolites, relaxation time, and behavioral analysis in TASTPM and wild-type mice.Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease.Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in ADAPOE genotype and age modifies the correlation between cognitive status and metabolites from hippocampus by a 2D (1)H-MRS in non-demented eldersProton magnetic resonance spectroscopy of the thalamus in patients with osteoarthritis of the hipMyo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease.Evidence for altered hippocampal volume and brain metabolites in workers occupationally exposed to lead: a study by magnetic resonance imaging and (1)H magnetic resonance spectroscopyCholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A2 enzyme.1H magnetic resonance spectroscopy in dementia.Hippocampal volumes, proton magnetic resonance spectroscopy metabolites, and cerebrovascular disease in mild cognitive impairment subtypes.Biomarkers for evaluation of clinical efficacy of multipotential neuroprotective drugs for Alzheimer's and Parkinson's diseases.1H MR spectroscopy in common dementiasLongitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's diseaseElevated brain scyllo-inositol concentrations in patients with Alzheimer's disease.Biomarkers for prediction and targeted prevention of Alzheimer's and Parkinson's diseases: evaluation of drug clinical efficacy.Cognitive impairment: classification by 1H magnetic resonance spectroscopy.
P2860
Q27307692-44EF8273-3DEE-4DEB-B5F1-FA390EAE3785Q30606675-364970F8-6E91-45DA-862E-704BEF757EE4Q30630699-813C0B90-22E3-4FD9-90EF-0C79F2A443DCQ30660402-27677F75-84FD-4F80-96B8-011F68BDC8DBQ30660816-0ECA24A3-644E-4AEB-B254-89CF23003F48Q30666607-45DE465C-F1D6-482E-AEA0-E49C1E2639CEQ30803093-5D91C991-71EB-4A6F-9A0E-12AF2FE38A2EQ30815106-4CB8C60F-7C85-4E8E-BDE2-9836991E2E23Q30836861-672E9AA6-5C1D-46B0-A8C2-CF48C0BE7E78Q30945792-54B3B015-C774-46E9-B020-2E9CB6505E8FQ30975605-F2DB07F8-402A-45FE-A98A-014C5E73F961Q30983010-1C1D9AC3-5CD8-4DD3-929E-170082D4736DQ30989943-A55F03AE-52E8-466A-8F69-F62EDF35D540Q30994832-48F4880B-DC06-4642-8D88-5D73B14B6EACQ30996805-3F04E63D-7776-494D-A3B9-E0762197B707Q31029801-C0AA6E37-D977-4567-A6C7-24E2081AC36DQ31047131-964570E5-8733-455A-9047-A4583D2E891EQ31049661-CD1A61DA-148F-4EB4-8390-80F199C7419AQ31097717-A15E2C2B-B0A9-4F0B-A907-7C926BC5222EQ31159878-BB055A2B-FFCF-4D5E-835E-B10D237D1964Q33277156-C07CB240-B504-4894-9E5F-53CCF8C5BCA0Q33392325-AF2EA010-A544-4EBF-815F-497D3D5E5DD8Q33990570-1A038FF1-48EE-40E8-AA3D-01189AF8B321Q34095846-F2829BF4-E9DA-4172-97BB-7261A1B970FFQ34325302-2534C385-8B87-451E-B1CF-119B7CE27D11Q34852161-0A96BC7B-9EB1-459D-AB1B-23B4FC45AC27Q35749793-8685BB9C-7F65-4AF2-AF1D-94FE7936B141Q36083501-D09C81CA-0CC3-4B83-84E1-6CA3A2E77143Q36765432-349E9851-5238-4E5B-ACE4-A48F5EE0DCB4Q36887148-BFFD76B3-B94C-42C2-8F8D-0742C18ACF1FQ37073878-EA439696-D24A-4D69-8B4D-0082096E1CE5Q37130148-C4007F55-9761-4D78-A89C-864E9CC61C4DQ37150637-731501FE-CD6A-4D50-978A-38D23378D933Q37345411-E7F2909A-3D15-4ED5-A232-A47005AA1621Q37358672-2ED42C31-ECA1-4A1C-AC7D-8D75B1A5B4E5Q37398605-9943FEA2-44C1-46F0-818A-1A24DEFCC97EQ37398634-1AD536A2-17DD-4E58-A6EB-81A1C8EB378CQ40243026-2805CE2A-F182-4736-93AC-D0EDA38CC63BQ42126269-C9ABA238-613C-4077-89D7-B2F67D0C2107Q44791946-5CFA5CCB-A3D0-4669-B1C0-6A96155979F9
P2860
Proton MR spectroscopy detects a relative decrease of N-acetylaspartate in the medial temporal lobe of patients with AD.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Proton MR spectroscopy detects ...... oral lobe of patients with AD.
@en
Proton MR spectroscopy detects ...... oral lobe of patients with AD.
@nl
type
label
Proton MR spectroscopy detects ...... oral lobe of patients with AD.
@en
Proton MR spectroscopy detects ...... oral lobe of patients with AD.
@nl
prefLabel
Proton MR spectroscopy detects ...... oral lobe of patients with AD.
@en
Proton MR spectroscopy detects ...... oral lobe of patients with AD.
@nl
P2093
P356
P1433
P1476
Proton MR spectroscopy detects ...... oral lobe of patients with AD.
@en
P2093
Lamerichs R
Papassotiropoulos A
P304
P356
10.1212/WNL.55.5.684
P407
P577
2000-09-01T00:00:00Z